ENZON PHARMACEUTICALS INC
ENZN
ENZN was delisted on the 19th of May, 2016.
49 hedge funds and large institutions have $12.7M invested in ENZON PHARMACEUTICALS INC in 2015 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 5 increasing their positions, 19 reducing their positions, and 9 closing their positions.
100% more call options, than puts
Call options by funds: $2K | Put options by funds: $1K
8% less funds holding
Funds holding: 53 → 49 (-4)
31% less capital invested
Capital invested by funds: $18.4M → $12.7M (-$5.67M)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
74% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 19
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCP
Seizert Capital Partners
Birmingham,
Michigan
|
+$329K |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$92K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$32K |
| 4 |
AFM
Anson Funds Management
Dallas,
Texas
|
+$19.8K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$18.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Globeflex Capital
San Diego,
California
|
-$243K |
| 2 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$126K |
| 3 |
ARTA
A.R.T. Advisors
New York
|
-$78K |
| 4 |
Morgan Stanley
New York
|
-$71.4K |
| 5 |
CL
CSS LLC
Chicago,
Illinois
|
-$49.4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WT
51
Whittier Trust
South Pasadena,
California
| – | -$444 | -560 | -83% |
|
52
Citigroup
New York
| – | -$4 | -5 | -10% |
|
53
Simplex Trading
Chicago,
Illinois
| – | +$79 | +100 | New |
|
54
JP Morgan Chase
New York
| – | +$270 | +340 | New |
|
ENZN Hedge Fund Activity: Q4 2015 in Review
49 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in ENZON PHARMACEUTICALS INC (ENZN) for Q4 2015, worth a combined $12.7M — down 31% from $18.4M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of ENZN and 5 opened new positions — a net loss of 4 holders — while 19 trimmed existing stakes and 5 added.
The largest buyer was Seizert Capital Partners, opening a new position worth an estimated $329K. The largest seller was Globeflex Capital, exiting entirely with an estimated $243K sold.
- 49 institutional investors held ENZON PHARMACEUTICALS INC (ENZN) as of Q4 2015, down from 53 in Q3 2015.
- Funds reported $12.7M of ENZON PHARMACEUTICALS INC stock for Q4 2015, down 31% quarter-over-quarter.
- 5 funds opened new ENZON PHARMACEUTICALS INC positions in Q4 2015 and 9 closed out, a net change of -4 holders.
- The largest ENZON PHARMACEUTICALS INC buyer in Q4 2015 was Seizert Capital Partners, an estimated $329K added.
- The largest ENZON PHARMACEUTICALS INC seller in Q4 2015 was Globeflex Capital, an estimated $243K sold.
Based on aggregated 13F filings for Q4 2015.